Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ACB
SELLREMOVEAurora Cannabis Inc. · Healthcare · Canada · $181M · Avg Vol: $3M/d
Aurora Cannabis is an unprofitable operator in a structurally broken industry. It lacks pricing power, has a history of massive shareholder dilution, and does not meet any of our quality or macro criteria.
COMPANY DESCRIPTION
Aurora Cannabis Inc. is a global leader in the cannabis industry, producing and distributing medical and consumer cannabis products. The company's competitive moat lies in its state-of-the-art, high-efficiency production facilities and its leading market share in the high-margin international medical cannabis segment. It operates as a prominent, vertically integrated player navigating evolving global regulatory frameworks.
FINANCIAL SUMMARY (USD)
| Year | 2021 | 2022 | 2024 | 2025 | 2026 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | — | 156.2M | 190.3M | 203.9M | 226.3M | 13.1% |
| EPS | -28.94 | -27.11 | -1.07 | 0.03 | — | — |
| Shares | — | 61.9M | 54.5M | 56.2M | 58.9M | -4.8% |
| Debt | 206.9M | 190.2M | 74.0M | 73.8M | 16.8M | -46.6% |
| Equity | — | 467.1M | 395.1M | 400.3M | 361.2M | -8.2% |
| Op CF | — | -77.8M | -48.3M | 11.3M | -9.5M | — |
| Inv CF | — | -25.5M | -2.4M | -10.1M | -51.2M | — |
| Fin CF | — | 104.3M | -33.8M | -81,866 | 6.9M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ACB are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ACB | Aurora Cannabis Inc.(you) | $181M | 30 | SELL |
| OGI | Organigram Global Inc. | $138M | 31 | SELL |
| CRDL.TO | Cardiol Therapeutics Inc. | $123M | 22 | SELL |
| NVRS.CN | Noveris Health Sciences Inc. | $64M | 23 | SELL |
| LEEF.CN | Leef Brands Inc. | $46M | 29 | SELL |
| WEED.TO | Canopy Growth Corporation | $501M | 21 | SELL |
| TLRY.TO | Tilray Brands, Inc. | $781M | 29 | SELL |
| HLS.TO | HLS Therapeutics Inc. | $100M | 63 | HOLD |
| DB.V | Decibel Cannabis Company Inc. | $50M | 60 | HOLD |
| CRON | Cronos Group Inc. | $1.0B | 56 | HOLD |
Peer medians: ROE -48.5% · P/E 14.3x · Gross margin 30.1%